Related by context. Frequent words. (Click for all words.) 71 Initiate Phase 69 Pivotal Phase 66 multicenter Phase 66 Completes Enrollment 64 Clinical Trial Results 64 II Clinical Trial 64 placebo controlled Phase 64 Pivotal Phase III 64 Metastatic Colorectal Cancer 64 Clinical Trials Update 63 Metastatic Melanoma 63 registrational trial 63 Presents Positive 63 Phase III Clinical Trial 63 Initiates Phase 62 relapsed refractory multiple myeloma 62 Patient Enrollment 62 Phase III Trial 62 HER2 positive metastatic breast 61 Ixempra 61 phase IIa 61 FDA Accepts 61 phase Ib 61 Daclizumab 61 relapsing multiple sclerosis 61 Pivotal Trial 61 metastatic castration resistant 61 metastatic hormone refractory 61 Pirfenidone 61 Chronic Hepatitis C 60 Alemtuzumab 60 Phase IIIb 60 Single Dose 60 plus prednisone 60 J Am Acad 60 Phase 2a clinical 60 Phase Ib clinical 60 randomized Phase III 60 multicenter randomized double 60 forodesine 59 Phase Ib II 59 multi kinase inhibitor 59 MKC# 59 Amrubicin 59 J Am Coll 59 See BioWorld Today 59 refractory chronic lymphocytic 59 phase IIb 59 pulmonology portfolio 59 Phase 1b 59 metastatic castrate resistant 59 Phase IIb trials 59 Preclinical Data 59 Drug Candidate 59 phase IIb clinical 59 elotuzumab 59 KRN# 59 CALGB 59 Gynecologic Oncology Group 58 Acute Myocardial Infarction 58 RADIANT 58 Phase III randomized 58 Pulmonary Arterial Hypertension 58 Denufosol 58 plus gemcitabine 58 randomized multicenter 58 Heart Failure Patients 58 Phase 2b clinical 58 Phase 2a trial 58 Tesetaxel 58 pivotal Phase 58 placebo controlled randomized 58 dose escalation trial 58 HALTS 58 Phase IIa clinical 58 sunitinib malate 58 Patients Treated 57 phase IIa clinical 57 Newly Diagnosed 57 plus dexamethasone 57 Chronic Lymphocytic Leukemia 57 Dasatinib 57 RIBBON 57 Phase 1b clinical 57 Gastrointestinal Cancers Symposium 57 Monotherapy 57 pivotal Phase III 57 Phase 1b trial 57 Panzem R 57 EVEREST II 57 placebo controlled clinical 57 Multicenter 57 Epratuzumab 57 Nasdaq AMGN 56 mRCC 56 #st Annual Meeting 56 Phase 2b trial 56 painful diabetic neuropathy 56 Postmenopausal Women 56 confirmatory Phase III 56 Phase IIa trial